Home › NDC Lookup › RxCUI directory › RxCUI 1734686

Ertapenem 1000 MG Injection [Invanz] — RxCUI 1734686

RxNorm drug concept · Semantic branded drug
RxCUI 1734686 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1734686
Official nameErtapenem 1000 MG Injection [Invanz]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asInvanz 1 GM Injection; Invanz 1000 MG Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)47 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ertapenem Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ertapenem is used for serious bacterial infections — things like severe abdominal infections, complicated skin infections (including diabetic foot infections without bone involveme...
  • What kinds of infections does ertapenem treat?
  • No, ertapenem is not available as a pill. It's always given as an injection — either through an IV line into a vein or as a shot into a large muscle like the thigh or buttock. IV d...
  • How will I receive this medication — is it a pill?
📖 Read our full Ertapenem Injection guide →

🕸️ Concept Web — How Ertapenem 1000 MG Injection [Invanz] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ertapenem 1000 MG Injection [Invanz] RxCUI 1734686

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ertapenem 325642
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Invanz 352721
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ertapenem Injection 1734682
    • Ertapenem Injectable Product 1162505
    • Ertapenem Injection [Invanz] 1734685
    • Invanz Injectable Product 1173448
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ertapenem 1000 MG Injection SCD · 1734683
  • Ertapenem 1000 MG SCDC · 1734681
  • Ertapenem Injection SCDF · 1734682
  • Ertapenem Injectable Product SCDG · 1162505

Brand-Name Concepts

  • Ertapenem 1000 MG [Invanz] SBDC · 1734684
  • Ertapenem Injection [Invanz] SBDF · 1734685
  • Invanz Injectable Product SBDG · 1173448
  • Invanz BN · 352721

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1734686 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00006-3843-71 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0006-3843-71) / 1 INJECT... INVANZ Merck Sharp & Dohme LLC 2001-11-21
Observed labelers: Merck Sharp & Dohme LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.